Acute coronary syndromes - glycoprotein IIb/IIIa inhibitors (replaced by TA47)
Glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes
| Guidance type:
Technology appraisal
|
| Date issued:
September 2000
|
| Guidance currently being reviewed:
See review |
| Reference:
TA12 |
Documents
For healthcare professionals
For patients, carers and the public
Background information
|
Implementing this guidance
Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:
|
| Top |
